Prusky Lab
News & Impact

You are here

Reduction of Visual Impairment with Elamipretide in Rodent Models of Diabetes, Aging, and Retinitis Pigmentosa

Invited Talk
May 2019
Stealth Biotherapeutics, Inc, Boston, MA

We have had success in reducing visual impairment in rodent models of aging and retinal disease, by targeting and improving mitochondrial function with a drug called Elamipretide. The results have already stimulated successful human clinical trials for visual indications, and the approach holds promise to extend the visual healthspan as we age. 


Conditions & Recovery

Retinal Degenerative Diseases icon
These will double by 2050.
Vision Recovery icon
See better.

Research Methods